New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Imanté Eichelberger

Manager, Marketing & Communications

Imanté Eichelberger joined NephCure as Marketing and Communications Coordinator in March 2024. He has years of experience working with various non-profits in the digital and traditional marketing space. Impact fuels his passion, as he strives to utilize his gained skills to make a difference.

The son of a social worker, Imanté has much familiarity with the many obstacles families have to overcome when finding treatment for their loved ones. He lives in Los Angeles, by way of New York City, where he enjoys hiking, trips to the beach and attending art and music festivals.

Los Angeles, CA

Related News

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NEWS

NephCure Specialist of the Month: Dr. Fahad Aziz

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.